期刊文献+

贝那普利对高血压合并糖耐量低减患者血管舒张功能的影响 被引量:7

Influence of benazepril on endothelium-dependent diastolic function in hypertension patients with impaired glucose tolerance
在线阅读 下载PDF
导出
摘要 目的探讨贝那普利对高血压合并糖耐量低减(1GT)患者血管内皮依赖性舒张功能的影响。方法贝那普利10~20mg/d治疗高血压合并IGT患者40例,共6个月,分析治疗前后血压、空腹血糖(FPG)、糖负荷后2h血糖(2hPG)、空腹胰岛素(FINS)、胰岛素抵抗指数(HOMA—IR)、血浆一氧化氮(NO)的变化,利用高频超声血管技术检测贝那普利治疗前后肱动脉内皮依赖性舒张功能(EDD),计算其舒张内径的变化率(D)。结果与治疗前比较,治疗后患者的收缩压下降(P〈0.01),舒张压、FINS、HOMA—IR下降(P〈0.05),血浆NO水平、D升高(P〈0.05)。治疗前后D变化值(AD)分别与FINS、HOMA—IR、NO及它们的变化值AFINS、AHOMA—IR、ANO相关。结论贝那普利对高血压合并IGT患者在有效降压的同时,能明显改善内皮依赖性舒张功能。 Objective To explore the effects of benazepril on endothelium-dependent diastolic (EDD) function of brachial artery in hypertension patients with impaired glucose tolerance (IGT). Methods Forty hypertension patients with IGT were treated with benazepril 10-20 mg/d for six months. Before and after treatment, blood pressure, fast plasma glucose (FPG), 2-hour plasma glucose (2-h PG), fast insulin (FINS), insulin resistance index (HOMA-IR) , nitrogen monoxidum (NO) were determined. High-frequency ultrasonic imaging was used to detect the changes of brachial artery EDD function after administration with benazepril, then calculate diastolic inner diameter changing rate (D). Results Compared with pretherapy, the systolic blood pressure was reduced (P 〈0.01 ). The diastolic blood pressure, FINS, HO- MA-IR were decreased (P 〈0.05 ). The plasma NO and D were increased (P 〈0.05 ). Before treatment, D was correlated with FINS, HOMA-IR and plasma NO, the change of D before and after treatment was correlated with the change of FINS, HOMA-IR and plasma NO. Conclusions Benazepril can reduce the blood pressure, improve EDD function in hypertension patients with 1GT.
出处 《山东医药》 CAS 北大核心 2010年第8期29-31,共3页 Shandong Medical Journal
关键词 高血压 糖耐量 贝那普利 内皮依赖性舒张功能 hypertension glucose tolerance benazepril endothelium-dependent diastolic function
  • 相关文献

参考文献7

  • 1Semenkovich CF. Insulin resistance and atherosclerosis [ J]. Clin Invest, 2006,116(7) :1831-1822.
  • 2Laplante MA, Wu R, Moreau P, et al. Endothelin mediates superoxide production in angiotensin II induced hypertension in rats [J]. Free Radic Biol Med, 2005,38(5) :589-596.
  • 3Celemajer DS, Sorensen KE, Cooch VM, et al. Non-invasive defection of endothelial dysfunction is children and adults at risk of atherosclerosis [ J ]. Lancet, 1992,340 (7) : 1111-1117.
  • 4Ginsberg HN. Insulin resistance and cardiovascular disease [J]. J Clin Invest, 2000,106 (4) :453-458.
  • 5刘志军,刘晓方.高血压病和糖尿病的研究[J].医学综述,2004,10(11):664-665. 被引量:6
  • 6张铁梅,徐秀英.缬沙坦和贝那普利对高血压患者肱动脉流量介导的舒张功能的干预作用[J].华西药学杂志,2005,20(2):176-178. 被引量:2
  • 7Furuta M, Tsunoda K, Arita M, et al. Endothelium dependent vasodilation in type II diabetes mellitus [J]. Rinsho Byori, 2003,51 (11) :1111-1115.

二级参考文献25

  • 1董磊,姚崇华,张敏,赵冬.1979—1991年高血压患病率的变化趋势[J].心肺血管病杂志,1993,12(1):3-5. 被引量:3
  • 2Celemajer DS, Sorensen K, Ryall M, et al. Non - invasive detection of endothelial dysfunction in child and adults at risk of atherosclerosis[J]. Lancet, 1992,340:1111.
  • 3Take B, Uehata A, Akima T, et al. Endothelium- dependent flowmediated vasodilation in colonary and brachial arteries in suspected coronary artery disease[J]. Am J Cardio, 1998,82:1535.
  • 4Neunteufl T, Katzenschlager R, Hassan A, et al. Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease[J]. Atherosclerosis, 1997,129:111.
  • 5Robert F, Thomas H, Marwick M, et al. Noninvasive tests of vascular function and structure:Why and How to perform them[J]. American Heart J ,2001,141:695.
  • 6The conference on the treatment of hypertension in diabetes[ J]. Diabetes Care, 1996,19[ Suppl 1] :S107-S113.
  • 7Tight hlood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes UKPDS 38UK Prospective Diabetes Study Group[J]. BMJ, 1998,317(7160) :703-713.
  • 8Poch E, Giner V, Nunez DG, et al. Association of the G protein β3 subunit T allete with insulin resistance in essential hypertension[ J]. Clin Exper Hypertension, 2002,24 ( 5 ) : 345 -353.
  • 9Horlkawa Y, Oda N, Cox N J, et al. Genetic variation in the gene encoding calpain 10 is associated with type 2 diabetes mellitus[ J]. Nat Gent,2000,26(2) : 163-171.
  • 10Hanson L, Zanchatti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low dose asprine in patients with hypertension:Principle results of the Hypertension Optimal Treatment (HOT) randomized trial HOT study Group [ J ].Lancet, 1998, 351 (9118) :1755-1762.

共引文献6

同被引文献47

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部